<![CDATA[Gastrointestinal Cancer Update]]>be555bdf-1cbc-5350-8db0-5de9b2cfe19aMon, 13 Apr 2026 18:14:43 +0000Captivate.fmDr. Neil Lovehttps://artwork.captivate.fm/8c104f4d-e244-446d-b79b-09735385f84f/j6sp7yRb3vZGZpaZTaxWb1wr.pngGastrointestinal Cancer UpdateDr. Neil LoveDr. Neil LoveThis series bridges the gap between research and patient care by providing medical oncologists and hematologists with ongoing access to the perspectives and opinions of national and international clinical investigators with expertise in gastrointestinal cancers.https://www.researchtopractice.com/browse-tumor-types/colorectal-cancerfalseepisodichttps://feeds.captivate.fm/gastrointestinal-cancer/nopodcastLocalized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumLocalized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumDr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.

CME information and select publications here.

]]>Dr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.

CME information and select publications here.

]]>ac0989a2-c053-4491-b8d5-e56b52399724Mon, 13 Apr 2026 09:00:00 -040015:06falsefull24555524HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumHER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumDr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management.

CME information and select publications here.

]]>Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management.

CME information and select publications here.

]]>13718aa7-47d9-47aa-a69d-2e24cdb530f1Wed, 08 Apr 2026 06:30:00 -040015:45falsefull24545424Desmoid Tumors — Microlearning Activity 2 with Dr Ravin RatanDesmoid Tumors — Microlearning Activity 2 with Dr Ravin RatanDr Ravin Ratan from The University of Texas MD Anderson Cancer Center in Houston discusses available clinical data with treatment approaches for desmoid tumors, alongside clinical cases illustrating real-world application.

CME information and select publications here.

]]>Dr Ravin Ratan from The University of Texas MD Anderson Cancer Center in Houston discusses available clinical data with treatment approaches for desmoid tumors, alongside clinical cases illustrating real-world application.

CME information and select publications here.

]]>b45cab48-099f-4728-a3d6-5011c1d95301Tue, 07 Apr 2026 16:00:00 -040028:14falsefull24535324Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumImmunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumDr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Samuel Klempner from Massachusetts General Hospital in Boston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, and Dr John Strickler from Duke University in Durham, North Carolina, review relevant data supporting immunotherapy for patients with gastroesophageal cancers and recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium.

CME information and select publications here.

]]>Dr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Samuel Klempner from Massachusetts General Hospital in Boston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, and Dr John Strickler from Duke University in Durham, North Carolina, review relevant data supporting immunotherapy for patients with gastroesophageal cancers and recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium.

CME information and select publications here.

]]>c7a42ce3-84d2-43c4-88b3-6b9b3b246a8fFri, 03 Apr 2026 15:45:00 -040022:10falsefull24525224Localized Colorectal Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumLocalized Colorectal Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumDr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.

CME information and select publications here.

]]>Dr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.

CME information and select publications here.

]]>f10e277d-4d62-4b0f-86c6-1bbea5665bfbThu, 26 Mar 2026 15:00:00 -040017:11falsefull24515124Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumImmunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumDr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and moderator Dr Samuel Klempner from Massachusetts General Hospital in Boston review relevant data supporting immunotherapy for patients with gastroesophageal cancers and review recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium.

CME information and select publications here.

]]>Dr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and moderator Dr Samuel Klempner from Massachusetts General Hospital in Boston review relevant data supporting immunotherapy for patients with gastroesophageal cancers and review recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium.

CME information and select publications here.

]]>963563ea-410b-469f-a2fb-65289308113dTue, 24 Mar 2026 15:00:00 -040024:55falsefull24505024HER2-Positive Gastrointestinal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumHER2-Positive Gastrointestinal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumDr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management.

CME information and select publications here.

]]>Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management.

CME information and select publications here.

]]>30915595-39b8-46b8-bc25-36f20b27b2beThu, 19 Mar 2026 12:00:00 -040021:38falsefull24494924Desmoid Tumors — Microlearning Activity 1 with Dr Ravin RatanDesmoid Tumors — Microlearning Activity 1 with Dr Ravin RatanDr Ravin Ratan from The University of Texas MD Anderson Cancer Center in Houston discusses available clinical data with treatment approaches for desmoid tumors, alongside clinical cases illustrating real-world application.

CME information and select publications here.

]]>Dr Ravin Ratan from The University of Texas MD Anderson Cancer Center in Houston discusses available clinical data with treatment approaches for desmoid tumors, alongside clinical cases illustrating real-world application.

CME information and select publications here.

]]>73fba5a8-0a83-4feb-a04b-b52325dc903eMon, 16 Mar 2026 14:30:00 -040016:43falsefull24484824HER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumHER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers SymposiumDr Haley Ellis from Mass General Brigham Cancer Institute in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data and provide their perspectives on the management of HER2-positive GI cancers.

CME information and select publications here.

]]>Dr Haley Ellis from Mass General Brigham Cancer Institute in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data and provide their perspectives on the management of HER2-positive GI cancers.

CME information and select publications here.

]]>9da5f674-fc61-46ad-8a18-fe2f3c91cd05Sat, 14 Mar 2026 09:00:00 -040012:53falsefull24474724Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease AnalysisOncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease AnalysisDr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer.

NCPD information and select publications here.

]]>Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer.

NCPD information and select publications here.

]]>34b4eac9-61d2-4f7f-bd85-25e2ff043738Fri, 06 Mar 2026 14:55:00 -040058:59falsefull24464624Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease AnalysisColorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease AnalysisDr Stacey A Cohen from the University of Washington in Seattle, Dr Arvind Dasari from The University of Texas MD Anderson Cancer Center in Houston, and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora discuss the role of molecular residual disease assessment using circulating tumor DNA-based tools in the management of colorectal cancer.

CME information and select publications here.

]]>Dr Stacey A Cohen from the University of Washington in Seattle, Dr Arvind Dasari from The University of Texas MD Anderson Cancer Center in Houston, and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora discuss the role of molecular residual disease assessment using circulating tumor DNA-based tools in the management of colorectal cancer.

CME information and select publications here.

]]>875e4951-2466-4636-8049-a1328579e619Thu, 26 Feb 2026 15:00:00 -040002:00:23falsefull24454524Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan FakihSquamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan FakihDr Marwah Fakih from the City of Hope Comprehensive Cancer Center in Duarte, California, discusses current and potential therapeutic strategies for the treatment of squamous cell carcinoma of the anal canal.

CME information and select publications here.

]]>Dr Marwah Fakih from the City of Hope Comprehensive Cancer Center in Duarte, California, discusses current and potential therapeutic strategies for the treatment of squamous cell carcinoma of the anal canal.

CME information and select publications here.

]]>9b49a599-547e-492b-a6cc-b32ecbee2ca7Thu, 12 Feb 2026 15:00:00 -040037:15falsefull24444424Localized Colorectal Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers SymposiumLocalized Colorectal Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers SymposiumDr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.

CME information and select publications here.

]]>Dr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.

CME information and select publications here.

]]>b67be5f7-fa1e-4370-9b95-5bb83a8d4358Fri, 06 Feb 2026 15:00:00 -040001:31:15falsefull24434324Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers SymposiumImmunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers SymposiumDr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and Dr Samuel Klempner from Massachusetts General Hospital in Boston review relevant data supporting immunotherapy for patients with gastroesophageal cancers and review recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium.

CME information and select publications here.

]]>Dr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and Dr Samuel Klempner from Massachusetts General Hospital in Boston review relevant data supporting immunotherapy for patients with gastroesophageal cancers and review recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium.

CME information and select publications here.

]]>d587ce32-fce4-469d-badb-98e53d3a0761Mon, 02 Feb 2026 15:30:00 -040001:57:08falsefull24424224HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers SymposiumHER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers SymposiumDr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel KankeuFonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management.

CME information and select publications here.

]]>Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel KankeuFonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management.

CME information and select publications here.

]]>c8e86156-5ddc-4a8b-82f1-4908c63cd6a5Wed, 28 Jan 2026 14:15:00 -040001:28:40falsefull24414124Colorectal Cancer — 5-Minute Journal Club Issue 2 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA AssaysColorectal Cancer — 5-Minute Journal Club Issue 2 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA AssaysDr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer.

CME information and select publications here.

]]>Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer.

CME information and select publications here.

]]>d978d8bc-22c7-4631-a22f-b2b6defee15bMon, 12 Jan 2026 18:36:00 -040025:18falsefull24404024Colorectal Cancer — 5-Minute Journal Club Issue 1 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA AssaysColorectal Cancer — 5-Minute Journal Club Issue 1 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA AssaysDr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer.

CME information and select publications here.

]]>Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer.

CME information and select publications here.

]]>e6c5fe7e-948b-4e16-8770-eaa7d25e5aa3Tue, 06 Jan 2026 15:00:00 -040022:33falsefull24393924Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2Dr Yelena Janjigian from Memorial Sloan Kettering Cancer Center in New York, New York, discusses updates across the treatment landscape for gastroesophageal cancers, as well as real-world clinical case examples.

CME information and select publications here.

]]>Dr Yelena Janjigian from Memorial Sloan Kettering Cancer Center in New York, New York, discusses updates across the treatment landscape for gastroesophageal cancers, as well as real-world clinical case examples.

CME information and select publications here.

]]>085fff88-6f9e-4cdb-8de6-be65833343a6Mon, 22 Dec 2025 09:00:00 -040001:00:36falsefull24383824Gastroesophageal Cancers — Proceedings from a Symposium Held in Partnership with the American Oncology NetworkGastroesophageal Cancers — Proceedings from a Symposium Held in Partnership with the American Oncology NetworkDr Manish A Shah from Weill Cornell Medicine in New York, New York, summarizes the treatment landscape and reviews relevant clinical datasets for patients with gastroesophageal cancers.     

CME information and select publications here.

]]>Dr Manish A Shah from Weill Cornell Medicine in New York, New York, summarizes the treatment landscape and reviews relevant clinical datasets for patients with gastroesophageal cancers.     

CME information and select publications here.

]]>24532029-8e4e-4fc6-b482-6ea568303419Sat, 13 Dec 2025 08:30:00 -040050:25falsefull24373724HER2-Positive Gastrointestinal Cancers — Clinical Investigator Perspectives on Actual Patient CasesHER2-Positive Gastrointestinal Cancers — Clinical Investigator Perspectives on Actual Patient CasesDr Tanios Bekaii-Saab and Dr Kristen K Ciombor summarize the treatment landscape and review key datasets in consideration of HER2-directed therapies for patients with HER2-positive gastrointestinal cancers. 

CME information and select publications here.

]]>Dr Tanios Bekaii-Saab and Dr Kristen K Ciombor summarize the treatment landscape and review key datasets in consideration of HER2-directed therapies for patients with HER2-positive gastrointestinal cancers. 

CME information and select publications here.

]]>1181322f-8a54-427c-ba62-28485cd2a433Fri, 21 Nov 2025 13:00:00 -040057:31falsefull24363624Colorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research InstituteColorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research InstituteDr Christopher Lieu and Dr John Strickler share their perspectives on the evolving therapeutic landscape for patients with colorectal cancer. 

CME information and select publications here.

]]>Dr Christopher Lieu and Dr John Strickler share their perspectives on the evolving therapeutic landscape for patients with colorectal cancer. 

CME information and select publications here.

]]>156078ce-f4f8-4458-a39a-a3982d797598Wed, 12 Nov 2025 16:49:00 -040001:04:25falsefull24353524Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease AnalysisColorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease AnalysisDr John Strickler from Duke University in Durham, North Carolina, discusses the measurement of molecular residual disease and its current and potential role in colorectal cancer risk assessment, surveillance and treatment decision-making. 

CME information and select publications here.

]]>Dr John Strickler from Duke University in Durham, North Carolina, discusses the measurement of molecular residual disease and its current and potential role in colorectal cancer risk assessment, surveillance and treatment decision-making. 

CME information and select publications here.

]]>7f4bc6db-ac5d-4a8f-a92a-3d94a451a99eThu, 30 Oct 2025 13:00:00 -040050:39falsefull24343424Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future ManagementExtrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future ManagementDr Jonathan Strosberg from Moffitt Cancer Center in Tampa, Florida, discusses recent updates on available and novel treatment strategies for extrapulmonary neuroendocrine carcinoma. 

CME information and select publications here.

]]>Dr Jonathan Strosberg from Moffitt Cancer Center in Tampa, Florida, discusses recent updates on available and novel treatment strategies for extrapulmonary neuroendocrine carcinoma. 

CME information and select publications here.

]]>d7363fbb-737b-4539-b3a1-8fe246b7e25bSun, 21 Sep 2025 09:00:00 -040044:34falsefull24333324Biliary Tract Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2Biliary Tract Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2Dr Haley Ellis and Dr James J Harding review actual patient cases and summarize clinical trial findings regarding the treatment of biliary tract cancers. 

CME information and select publications here.

]]>Dr Haley Ellis and Dr James J Harding review actual patient cases and summarize clinical trial findings regarding the treatment of biliary tract cancers. 

CME information and select publications here.

]]>ef558970-2a5c-4e70-9b0b-88d2b0c32f10Thu, 28 Aug 2025 14:40:00 -040059:15falsefull24323224HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual MeetingHER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual MeetingDr Haley Ellis from Massachusetts General Hospital in Boston, Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Dr Sara Lonardi from the Veneto Institute of Oncology IOV-IRCCS in Padua, Italy, and Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discuss patient cases and provide their perspectives on clinical datasets informing the care of patients with HER2-positive gastrointestinal cancer.  

CME information and select publications here.

]]>Dr Haley Ellis from Massachusetts General Hospital in Boston, Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Dr Sara Lonardi from the Veneto Institute of Oncology IOV-IRCCS in Padua, Italy, and Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discuss patient cases and provide their perspectives on clinical datasets informing the care of patients with HER2-positive gastrointestinal cancer.  

CME information and select publications here.

]]>3d47ec18-6f84-46e2-aabd-678d1fc4f5e0Tue, 15 Jul 2025 10:30:00 -040001:28:55falsefull24313124Colorectal Cancer — Proceedings from a Session Held During the 2025 ASCO Annual MeetingColorectal Cancer — Proceedings from a Session Held During the 2025 ASCO Annual MeetingDr Andrea Cercek from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Arvind Dasari from The University of Texas MD Anderson Cancer Center in Houston, Dr Pashtoon Kasi from City of Hope Orange County in Irvine, California, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, and Dr J Randolph Hecht from the UCLA David Geffen School of Medicine in Santa Monica, California, discuss recent updates on available and novel treatment strategies for colorectal cancer. 

CME information and select publications here.

]]>Dr Andrea Cercek from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Arvind Dasari from The University of Texas MD Anderson Cancer Center in Houston, Dr Pashtoon Kasi from City of Hope Orange County in Irvine, California, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, and Dr J Randolph Hecht from the UCLA David Geffen School of Medicine in Santa Monica, California, discuss recent updates on available and novel treatment strategies for colorectal cancer. 

CME information and select publications here.

]]>341ab4fa-1d46-48a2-a1f4-1b0271742bb5Wed, 02 Jul 2025 15:00:00 -040002:02:10falsefull24303024Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 1 of 2Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 1 of 2Dr Geoffrey Y Ku from the Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Zev Wainberg from the UCLA School of Medicine discuss patient cases and summarize current treatment approaches for gastroesophageal cancer. 

CME information and select publications here.

]]>Dr Geoffrey Y Ku from the Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Zev Wainberg from the UCLA School of Medicine discuss patient cases and summarize current treatment approaches for gastroesophageal cancer. 

CME information and select publications here.

]]>70eb35d9-52ef-4560-af5c-35adb608dd01Thu, 19 Jun 2025 15:00:00 -040001:01:04falsefull24292924For Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS CongressFor Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS CongressDr Sunnie Kim and Dr Manish Shah summarize the clinical treatment landscape for patients with gastroesophageal cancers, supported by clinical perspectives and management strategies from oncology nursing experts Ms Brooke Parker and Ms Michal Segal. 

NCPD information and select publications here.

]]>Dr Sunnie Kim and Dr Manish Shah summarize the clinical treatment landscape for patients with gastroesophageal cancers, supported by clinical perspectives and management strategies from oncology nursing experts Ms Brooke Parker and Ms Michal Segal. 

NCPD information and select publications here.

]]>ab8c41e8-418b-4be9-9f0b-75dc46431d5dThu, 12 Jun 2025 15:00:00 -040001:29:49falsefull24282824Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology SummitHepatocellular Carcinoma — Fourth Annual National General Medical Oncology SummitClinical investigators discuss available data guiding the management of hepatocellular carcinoma.  

CME information and select publications here.

]]>Clinical investigators discuss available data guiding the management of hepatocellular carcinoma.  

CME information and select publications here.

]]>042d396e-6fa7-4b98-bd35-121416ada3fbSun, 01 Jun 2025 16:13:00 -040051:04falsefull24272724For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2025 Annual ONS CongressFor Oncology Nurses: Pancreatic Cancer — Proceedings from the 2025 Annual ONS CongressDrs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events.  

NCPD information and select publications here.

]]>Drs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events.  

NCPD information and select publications here.

]]>4be1158e-eb1d-4bcb-91fb-eafcdf073c9bFri, 30 May 2025 16:00:00 -040001:33:16falsefull24262624Gastroesophageal Cancer — Fourth Annual National General Medical Oncology SummitGastroesophageal Cancer — Fourth Annual National General Medical Oncology SummitClinical investigators discuss available data guiding the management of gastroesophageal cancer.  

CME information and select publications here.

]]>Clinical investigators discuss available data guiding the management of gastroesophageal cancer.  

CME information and select publications here.

]]>f2c9d794-2dcf-44f0-aa16-5ab26e624ddfMon, 26 May 2025 09:00:00 -040052:32falsefull24252524Pancreatic Cancer — Fourth Annual National General Medical Oncology SummitPancreatic Cancer — Fourth Annual National General Medical Oncology SummitClinical investigators discuss available data guiding the management of pancreatic cancer.  

CME information and select publications here.

]]>Clinical investigators discuss available data guiding the management of pancreatic cancer.  

CME information and select publications here.

]]>c200f1e4-f834-4896-982f-be054f302bcfWed, 21 May 2025 14:00:00 -040049:14falsefull24242424Colorectal Cancer — Fourth Annual National General Medical Oncology SummitColorectal Cancer — Fourth Annual National General Medical Oncology SummitClinical investigators discuss available data guiding the management of colorectal cancer.  

CME information and select publications here.

]]>Clinical investigators discuss available data guiding the management of colorectal cancer.  

CME information and select publications here.

]]>21f62067-7cc0-4285-9463-6e6fedb66ee7Sat, 17 May 2025 12:00:00 -040050:09falsefull24232324Biliary Tract Cancers — Fourth Annual National General Medical Oncology SummitBiliary Tract Cancers — Fourth Annual National General Medical Oncology SummitClinical investigators discuss available data guiding the management of biliary tract cancers.  

CME information and select publications here.

]]>Clinical investigators discuss available data guiding the management of biliary tract cancers.  

CME information and select publications here.

]]>c91dfd82-d61c-456d-ac50-983441f40b02Sun, 27 Apr 2025 09:00:00 -040048:54falsefull24222224Neuroendocrine Tumors — Fourth Annual National General Medical Oncology SummitNeuroendocrine Tumors — Fourth Annual National General Medical Oncology SummitClinical investigators discuss available data guiding the management of neuroendocrine tumors.  

CME information and select publications here.

]]>Clinical investigators discuss available data guiding the management of neuroendocrine tumors.  

CME information and select publications here.

]]>a96b5dea-7f69-4607-8ab7-28521001b386Fri, 11 Apr 2025 17:19:00 -040050:16falsefull24212124Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L MoertelNeurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L MoertelDr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1. 

CME information and select publications here.

]]>Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1. 

CME information and select publications here.

]]>e0303f7d-1bd3-4753-b6b8-36619d32b064Fri, 28 Mar 2025 16:58:00 -040049:28falsefull24202024Colorectal Cancer — Year in Review Series on Relevant New Datasets and AdvancesColorectal Cancer — Year in Review Series on Relevant New Datasets and AdvancesDr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston and Dr Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston summarize the most clinically relevant research findings and data presented over the past year for patients with colorectal cancer. 

CME information and select publications here.

]]>Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston and Dr Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston summarize the most clinically relevant research findings and data presented over the past year for patients with colorectal cancer. 

CME information and select publications here.

]]>bf69fc1d-081f-4b4c-a07f-3d621e1efc55Sat, 15 Mar 2025 06:00:00 -040058:40falsefull24191924Biliary Tract Cancers — Reviewing Patient Cases with Prof John Bridgewater: Part 1 of 2Biliary Tract Cancers — Reviewing Patient Cases with Prof John Bridgewater: Part 1 of 2Dr John Bridgewater from the UCL Cancer Institute in London, United Kingdom, discusses patient cases and summarizes current treatment approaches for cholangiocarcinoma and other biliary tract cancers. 

CME information and select publications here.

]]>Dr John Bridgewater from the UCL Cancer Institute in London, United Kingdom, discusses patient cases and summarizes current treatment approaches for cholangiocarcinoma and other biliary tract cancers. 

CME information and select publications here.

]]>01f2c2ba-a838-4a64-ae96-6e7e091e0bffSat, 01 Mar 2025 09:00:00 -040058:00falsefull24181824Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)Dr Arvind Dasari, Dr Van Morris, Dr Jenny Seligmann, Prof Eric Van Cutsem and moderator Dr Christopher Lieu summarize research findings guiding the application of biomarker-driven therapy for patients with colorectal cancers during a session at the 2025 ASCO Gastrointestinal Cancers Symposium. 

CME information and select publications here.

]]>Dr Arvind Dasari, Dr Van Morris, Dr Jenny Seligmann, Prof Eric Van Cutsem and moderator Dr Christopher Lieu summarize research findings guiding the application of biomarker-driven therapy for patients with colorectal cancers during a session at the 2025 ASCO Gastrointestinal Cancers Symposium. 

CME information and select publications here.

]]>a3553b8b-a075-4cad-a611-39dad549aa7dSat, 22 Feb 2025 09:00:00 -040001:57:20falsefull24171724Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)Dr Anthony El-Khoueiry, Dr Richard Finn, Dr Aiwu Ruth He, Dr Stacey Stein and moderator Dr Stephen “Fred” Divers discuss data from the 2025 ASCO GI meeting and other published studies guiding the care of patients with hepatocellular carcinoma.

CME information and select publications here.

]]>Dr Anthony El-Khoueiry, Dr Richard Finn, Dr Aiwu Ruth He, Dr Stacey Stein and moderator Dr Stephen “Fred” Divers discuss data from the 2025 ASCO GI meeting and other published studies guiding the care of patients with hepatocellular carcinoma.

CME information and select publications here.

]]>fdb7b73f-2108-4e2b-a9d0-eb2904419fdfFri, 14 Feb 2025 18:18:00 -040001:58:47falsefull24161624Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal CancersCases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal CancersDr Christopher Lieu shares his perspectives on the evolving therapeutic landscape for patients with colorectal and gastroesophageal cancers.

]]>Dr Christopher Lieu shares his perspectives on the evolving therapeutic landscape for patients with colorectal and gastroesophageal cancers.

]]>E36E539F-9834-42BF-BA31-550A027F4436Wed, 18 Dec 2024 10:21:00 -040049:11falsefull24151524Dr Christopher Lieu shares his perspectives on the evolving therapeutic landscape for patients with colorectal and gastroesophageal cancers.Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary CancersCases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary CancersDr Daneng Li shares his perspectives on the evolving therapeutic landscape for patients with hepatobiliary cancers.

]]>Dr Daneng Li shares his perspectives on the evolving therapeutic landscape for patients with hepatobiliary cancers.

]]>02CF8F23-1A24-46B6-87DF-EB910FF4533BWed, 18 Dec 2024 10:20:00 -040055:49falsefull24141424Dr Daneng Li shares his perspectives on the evolving therapeutic landscape for patients with hepatobiliary cancers.The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 ReviewThe Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 ReviewDr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Ford Cancer Institute in Detroit, Michigan, discuss recent research presentations on the treatment of gastrointestinal cancers.

]]>Dr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Ford Cancer Institute in Detroit, Michigan, discuss recent research presentations on the treatment of gastrointestinal cancers.

]]>FA4CA44D-FEA0-402F-BABA-4148233C2E21Wed, 06 Nov 2024 12:39:00 -040001:02:25falsefull24131324Dr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Ford Cancer Institute in Detroit, Michigan, discuss recent research presentations on the treatment of gastrointestinal cancers.Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid TumorsPractical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid TumorsDr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for desmoid tumors and review novel options for targeted therapy.

]]>Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for desmoid tumors and review novel options for targeted therapy.

]]>74FA46AD-0621-4E91-B681-23A6BAA2D511Fri, 18 Oct 2024 12:39:00 -040059:22falsefull24121224Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for desmoid tumors and review novel options for targeted therapy.Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract CancersStriving for Consensus: Optimizing the Current and Future Management of Biliary Tract CancersDr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field.

]]>Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field.

]]>B7B5D862-F062-47A8-8487-764B1C2CA5B0Fri, 20 Sep 2024 13:32:00 -040002:14:52falsefull24111124Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field.Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine TumorsInside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine TumorsDr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.

]]>Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.

]]>16080765-4367-4BDC-A7A1-D0A762F3260CThu, 19 Sep 2024 08:25:00 -040059:20falsefull24101024Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal CancersInside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal CancersDr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.

]]>Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.

]]>C34A33FA-7277-41A8-8533-F9462A4DFD9CFri, 13 Sep 2024 14:34:00 -040001:00:59falsefull249924Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated LiposarcomaOncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated LiposarcomaDr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.

]]>Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.

]]>8297C777-E0FD-451D-8126-36D196480BEATue, 10 Sep 2024 10:45:00 -040001:15:13falsefull248824Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal CancerRTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal CancerDr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.

]]>Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.

]]>3DF4D95F-4353-4158-84FA-C4D11D3EB80FTue, 16 Jul 2024 11:36:00 -040001:02:36falsefull247724Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.Year in Review: Novel Treatments and Strategies in Gastroesophageal CancerYear in Review: Novel Treatments and Strategies in Gastroesophageal CancerProf Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.

]]>Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.

]]>7C860A8C-0FBD-4C42-AAE3-F4079D337936Fri, 03 May 2024 13:10:00 -040059:47falsefull246624Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part EditionOncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part EditionDr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer.

]]>Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer.

]]>1AC3E347-8D6B-466C-A0B4-2A251A34A04DTue, 16 Apr 2024 09:57:00 -040037:24falsefull245524Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal CancerYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal CancerProfessor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.

]]>Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.

]]>4DF82D61-1EC8-4CDD-95CB-6577E6B7ED62Mon, 08 Apr 2024 09:59:00 -040058:43falsefull244424Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium ReviewConsensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium ReviewDr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellular carcinoma and biliary tract cancers.

]]>Dr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellular carcinoma and biliary tract cancers.

]]>78A13909-4890-416F-86C9-171D6232FF0AThu, 21 Mar 2024 08:43:00 -040001:01:41falsefull243324Dr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellular carcinoma and biliary tract cancers.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal CancersYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal CancersDr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field.

]]>Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field.

]]>61D7C1DA-3E65-4EDE-8FA2-0B438AC7ECFBThu, 07 Mar 2024 09:48:00 -040001:02:36falsefull242224Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field.Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary CancersConsensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary CancersDr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers.

]]>Dr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers.

]]>CF23E1D2-9A8D-4ECC-98ED-7671822225BDFri, 23 Feb 2024 10:04:00 -040001:00:34falsefull241124Dr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers.Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract CancersInside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract CancersDr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston discuss targeted and immunotherapeutic approaches for biliary tract cancers.

]]>Dr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston discuss targeted and immunotherapeutic approaches for biliary tract cancers.

]]>9CF078B4-5483-479D-96DD-436CA188CA65Thu, 14 Dec 2023 09:01:00 -040001:00:26falsefull23252523Dr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston discuss targeted and immunotherapeutic approaches for biliary tract cancers.Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part SeriesMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part SeriesDr Samuel J Klempner from Massachusetts General Hospital in Boston discusses optimizing the management of gastroesophageal cancers.

]]>Dr Samuel J Klempner from Massachusetts General Hospital in Boston discusses optimizing the management of gastroesophageal cancers.

]]>CB59CC5B-986B-47C1-B6F4-B4ADAA2CDA7FWed, 06 Dec 2023 09:58:00 -040001:01:54falsefull23242423Dr Samuel J Klempner from Massachusetts General Hospital in Boston discusses optimizing the management of gastroesophageal cancers.Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part SeriesMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part SeriesProf Eric Van Cutsem from the University Hospitals Leuven in Leuven, Belgium, discusses optimizing the management of gastroesophageal cancers.

]]>Prof Eric Van Cutsem from the University Hospitals Leuven in Leuven, Belgium, discusses optimizing the management of gastroesophageal cancers.

]]>241754AA-639E-46BC-A1AC-041430DC6DEAWed, 15 Nov 2023 12:48:00 -040001:02:51falsefull23232323Prof Eric Van Cutsem from the University Hospitals Leuven in Leuven, Belgium, discusses optimizing the management of gastroesophageal cancers.Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part SeriesMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part SeriesFeaturing a discussion on current and emerging strategies for the treatment of upper GI cancers with Dr Peter C Enzinger, moderated by Dr Neil Love.

]]>Featuring a discussion on current and emerging strategies for the treatment of upper GI cancers with Dr Peter C Enzinger, moderated by Dr Neil Love.

]]>87A5D97D-4261-4DC9-863E-2B9618F6C68FMon, 23 Oct 2023 11:13:00 -040001:03:02falsefull23222223Featuring a discussion on current and emerging strategies for the treatment of upper GI cancers with Dr Peter C Enzinger, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael PishvaianOncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael PishvaianDr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discusses recent updates on available and novel treatment strategies for pancreatic cancer.

]]>Dr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discusses recent updates on available and novel treatment strategies for pancreatic cancer.

]]>7A6E24B7-0F2A-4CFC-A726-ACEFB52C1CDAFri, 13 Oct 2023 14:28:00 -040057:57falsefull23212123Dr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discusses recent updates on available and novel treatment strategies for pancreatic cancer.Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal CancerPractical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal CancerDr Kristen K Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Dr J Randolph Hecht from UCLA’s David Geffen School of Medicine in Santa Monica, California, discuss the current management and actual cases of relapsed/refractory metastatic colorectal cancer.

]]>Dr Kristen K Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Dr J Randolph Hecht from UCLA’s David Geffen School of Medicine in Santa Monica, California, discuss the current management and actual cases of relapsed/refractory metastatic colorectal cancer.

]]>EB96B0F3-59D2-4868-B364-C526F633588BFri, 06 Oct 2023 10:17:00 -040001:05:23falsefull23202023Dr Kristen K Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Dr J Randolph Hecht from UCLA’s David Geffen School of Medicine in Santa Monica, California, discuss the current management and actual cases of relapsed/refractory metastatic colorectal cancer.Inside the Issue: Optimizing the Management of Metastatic Pancreatic CancerInside the Issue: Optimizing the Management of Metastatic Pancreatic CancerDr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer.

]]>Dr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer.

]]>F59BCFEF-5211-4939-946D-23FB6DC5DECEMon, 18 Sep 2023 10:28:00 -040001:03:48falsefull23191923Dr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer.The Implications of Recent Data Sets for the Management of Hepatocellular CarcinomaThe Implications of Recent Data Sets for the Management of Hepatocellular CarcinomaDr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte, California, discuss the implications of recent data sets for the management of hepatocellular carcinoma.

]]>Dr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte, California, discuss the implications of recent data sets for the management of hepatocellular carcinoma.

]]>BA830CF2-360E-4711-A459-9A0FE0F240AFWed, 06 Sep 2023 11:41:00 -040001:02:04falsefull23181823Dr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte, California, discuss the implications of recent data sets for the management of hepatocellular carcinoma.Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part SeriesMeet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part SeriesDr Richard F Riedel from Duke Cancer Institute in Durham, North Carolina, discusses approved and novel treatment approaches for soft tissue sarcoma, moderated by Dr Neil Love.

]]>Dr Richard F Riedel from Duke Cancer Institute in Durham, North Carolina, discusses approved and novel treatment approaches for soft tissue sarcoma, moderated by Dr Neil Love.

]]>57C5A5D9-E27D-4B2E-91D2-71FCC39488B3Wed, 30 Aug 2023 11:14:00 -040001:01:53falsefull23171723Dr Richard F Riedel from Duke Cancer Institute in Durham, North Carolina, discusses approved and novel treatment approaches for soft tissue sarcoma, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingOncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingFeaturing a discussion on key presentations related to gastrointestinal cancers from the 2023 ASCO Annual Meeting, with Dr Philip Philip, moderated by Dr Neil Love.

]]>Featuring a discussion on key presentations related to gastrointestinal cancers from the 2023 ASCO Annual Meeting, with Dr Philip Philip, moderated by Dr Neil Love.

]]>16AF633B-0AC1-4E3F-8BBA-845FFC1D8909Wed, 16 Aug 2023 09:41:00 -040049:02falsefull23161623Featuring a discussion on key presentations related to gastrointestinal cancers from the 2023 ASCO Annual Meeting, with Dr Philip Philip, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal CancersOncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal CancersDr Tanios Bekaii-Saab from the Mayo Clinic in Phoenix, Arizona, discusses the role of novel therapeutic management approaches for patients with colorectal and gastroesophageal cancers, moderated by Dr Neil Love. Produced by Research To Practice.

]]>Dr Tanios Bekaii-Saab from the Mayo Clinic in Phoenix, Arizona, discusses the role of novel therapeutic management approaches for patients with colorectal and gastroesophageal cancers, moderated by Dr Neil Love. Produced by Research To Practice.

]]>629C0875-9DCE-4CDA-838C-9F0DD67C8F65Thu, 03 Aug 2023 08:48:00 -040058:45falsefull23151523Dr Tanios Bekaii-Saab from the Mayo Clinic in Phoenix, Arizona, discusses the role of novel therapeutic management approaches for patients with colorectal and gastroesophageal cancers, moderated by Dr Neil Love. Produced by Research To Practice.Oncology Today with Dr Neil Love: Special Edition — Management of Hepatobiliary CancersOncology Today with Dr Neil Love: Special Edition — Management of Hepatobiliary CancersDr Robin “Katie” Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California discusses recent updates from ASCO 2023 on the management of hepatobiliary cancers, moderated by Dr Neil Love.

]]>Dr Robin “Katie” Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California discusses recent updates from ASCO 2023 on the management of hepatobiliary cancers, moderated by Dr Neil Love.

]]>D99A5730-D579-4299-BBEB-2350265A8861Tue, 25 Jul 2023 10:58:00 -040053:24falsefull23141423Dr Robin “Katie” Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California discusses recent updates from ASCO 2023 on the management of hepatobiliary cancers, moderated by Dr Neil Love.What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Colorectal and Gastroesophageal CancersWhat I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Colorectal and Gastroesophageal CancersFeaturing a discussion on the management of colorectal and gastroesophageal cancers with Dr Kristen K Ciombor and Mrs Amanda K Wagner, moderated by Dr Neil Love.

]]>Featuring a discussion on the management of colorectal and gastroesophageal cancers with Dr Kristen K Ciombor and Mrs Amanda K Wagner, moderated by Dr Neil Love.

]]>C3C850D5-B49B-478D-B92A-129854EBFCE7Fri, 07 Jul 2023 12:37:00 -040001:01:34falsefull23131323Featuring a discussion on the management of colorectal and gastroesophageal cancers with Dr Kristen K Ciombor and Mrs Amanda K Wagner, moderated by Dr Neil Love.Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part SeriesMeet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part SeriesFeaturing a discussion on the management of soft tissue sarcoma and related connective tissue disorders with Dr Brian Van Tine, moderated by Dr Neil Love.

]]>Featuring a discussion on the management of soft tissue sarcoma and related connective tissue disorders with Dr Brian Van Tine, moderated by Dr Neil Love.

]]>3F004201-3E62-4DE2-AC30-9DF2CF8F3367Fri, 16 Jun 2023 10:45:00 -040001:01:32falsefull23121223Featuring a discussion on the management of soft tissue sarcoma and related connective tissue disorders with Dr Brian Van Tine, moderated by Dr Neil Love.Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 3 of a 3-Part SeriesMeet The Professor: Optimizing the Management of Colorectal Cancer — Part 3 of a 3-Part SeriesFeaturing a discussion on the management of colorectal cancer with Dr Michael J Overman, moderated by Dr Neil Love.

]]>Featuring a discussion on the management of colorectal cancer with Dr Michael J Overman, moderated by Dr Neil Love.

]]>090212A5-E5DD-4860-8AFC-5F4DD30B1C09Thu, 08 Jun 2023 10:16:00 -040058:27falsefull23111123Featuring a discussion on the management of colorectal cancer with Dr Michael J Overman, moderated by Dr Neil Love.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary CancersYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary CancersProceedings from our Year in Review webinar on colorectal cancer. Featuring perspectives from Drs Ghassan Abou‑Alfa and Richard S Finn, moderated by Dr Neil Love.

]]>Proceedings from our Year in Review webinar on colorectal cancer. Featuring perspectives from Drs Ghassan Abou‑Alfa and Richard S Finn, moderated by Dr Neil Love.

]]>153005FF-DF1E-4214-A810-0696C3DCA885Fri, 19 May 2023 10:00:00 -040001:03:03falsefull23101023Proceedings from our Year in Review webinar on colorectal cancer. Featuring perspectives from Drs Ghassan Abou‑Alfa and Richard S Finn, moderated by Dr Neil Love.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal CancerYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal CancerProceedings from our Year in Review webinar on colorectal cancer. Featuring perspectives from Drs Pashtoon M Kasi and Wells A Messersmith, moderated by Dr Neil Love.

]]>Proceedings from our Year in Review webinar on colorectal cancer. Featuring perspectives from Drs Pashtoon M Kasi and Wells A Messersmith, moderated by Dr Neil Love.

]]>B094A32A-3CA7-43E4-ACC3-F4E227F7699DTue, 09 May 2023 10:49:00 -040001:00:42falsefull239923Proceedings from our Year in Review webinar on colorectal cancer. Featuring perspectives from Drs Pashtoon M Kasi and Wells A Messersmith, moderated by Dr Neil Love.Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 2 of a 3-Part SeriesMeet The Professor: Optimizing the Management of Colorectal Cancer — Part 2 of a 3-Part SeriesFeaturing a discussion on the management of colorectal cancer with Dr John Strickler, moderated by Dr Neil Love.

]]>Featuring a discussion on the management of colorectal cancer with Dr John Strickler, moderated by Dr Neil Love.

]]>3AC7D80B-2FBC-4557-B711-7B56F8E8E2B1Fri, 07 Apr 2023 13:19:00 -040001:00:01falsefull238823Featuring a discussion on the management of colorectal cancer with Dr John Strickler, moderated by Dr Neil Love.Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal and Hepatobiliary Cancers — A 2023 Post-ASCO GI WebcastCases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal and Hepatobiliary Cancers — A 2023 Post-ASCO GI WebcastFeaturing perspectives from Drs Eric Lee, Neil Morganstein and Swati Vishwanathan, moderated by Dr Neil Love.

]]>Featuring perspectives from Drs Eric Lee, Neil Morganstein and Swati Vishwanathan, moderated by Dr Neil Love.

]]>DB6CF8C5-5401-48FC-A30F-1C7AF3C55577Tue, 04 Apr 2023 10:41:00 -040001:00:32falsefull237723Featuring perspectives from Drs Eric Lee, Neil Morganstein and Swati Vishwanathan, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Special Edition — Current Management of Hepatobiliary CancersOncology Today with Dr Neil Love: Special Edition — Current Management of Hepatobiliary CancersFeaturing perspectives from Dr Lipika Goyal, moderated by Dr Neil Love.

]]>Featuring perspectives from Dr Lipika Goyal, moderated by Dr Neil Love.

]]>9232A8AC-C3B6-4904-ABAE-37C424044CA3Tue, 04 Apr 2023 10:41:00 -040058:10falsefull236623Featuring perspectives from Dr Lipika Goyal, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Special Edition — Current Management of Gastroesophageal CancersOncology Today with Dr Neil Love: Special Edition — Current Management of Gastroesophageal CancersFeaturing perspectives from Dr Zev Wainberg, moderated by Dr Neil Love.

]]>Featuring perspectives from Dr Zev Wainberg, moderated by Dr Neil Love.

]]>2388C602-5522-4038-AF9F-FCE512FB16DBTue, 04 Apr 2023 10:40:00 -040052:14falsefull235523Featuring perspectives from Dr Zev Wainberg, moderated by Dr Neil Love.Recent Advances and Future Directions in Gastrointestinal Cancers — With Dr Tanios Bekaii-Saab and Dr Rutika Mehta (Proceedings from a Symposium in Partnership with NCOA and SCOS)Recent Advances and Future Directions in Gastrointestinal Cancers — With Dr Tanios Bekaii-Saab and Dr Rutika Mehta (Proceedings from a Symposium in Partnership with NCOA and SCOS)Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

]]>Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

]]>8D425461-70ED-4DEE-868E-1000A73584A2Fri, 17 Mar 2023 12:37:00 -040001:00:44falsefull234423Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 1 of a 3-Part SeriesMeet The Professor: Optimizing the Management of Colorectal Cancer — Part 1 of a 3-Part SeriesFeaturing a discussion on the management of colorectal cancer with Dr Christopher Lieu, moderated by Dr Neil Love.

]]>Featuring a discussion on the management of colorectal cancer with Dr Christopher Lieu, moderated by Dr Neil Love.

]]>371BC576-3CF6-4E70-BE9C-93B605214CC2Tue, 14 Mar 2023 10:19:00 -040001:03:24falsefull233323Featuring a discussion on the management of colorectal cancer with Dr Christopher Lieu, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Management of Desmoid TumorsOncology Today with Dr Neil Love: Management of Desmoid TumorsFeaturing a discussion on the management of desmoid tumors with Dr Mrinal Gounder, moderated by Dr Neil Love.

]]>Featuring a discussion on the management of desmoid tumors with Dr Mrinal Gounder, moderated by Dr Neil Love.

]]>8118DCFE-E6B4-486C-B136-6CD0E4628B0DTue, 28 Feb 2023 09:51:00 -040054:25falsefull232223Featuring a discussion on the management of desmoid tumors with Dr Mrinal Gounder, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Management of Gastroesophageal CancersOncology Today with Dr Neil Love: Management of Gastroesophageal CancersFeaturing a discussion on current and emerging strategies for the treatment of upper GI malignancies with Dr Manish Shah, moderated by Dr Neil Love.

]]>Featuring a discussion on current and emerging strategies for the treatment of upper GI malignancies with Dr Manish Shah, moderated by Dr Neil Love.

]]>6F0EF6A7-E275-4535-80FF-F2635B0D81A1Thu, 12 Jan 2023 07:27:00 -040043:23falsefull231123Featuring a discussion on current and emerging strategies for the treatment of upper GI malignancies with Dr Manish Shah, moderated by Dr Neil Love.